Peter Kern

Author PubWeight™ 102.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 19.93
2 Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2009 7.90
3 European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003 3.80
4 Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012 3.12
5 Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 2007 2.92
6 Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 2009 2.12
7 Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 2009 2.04
8 Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis 2004 1.99
9 Cystic echinococcosis in sub-Saharan Africa. Lancet Infect Dis 2012 1.91
10 Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 2007 1.87
11 Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 2005 1.78
12 Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis 2004 1.68
13 Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006 1.56
14 Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health 2006 1.50
15 Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis 2004 1.46
16 [Fox tapeworm. Is there a risk also in our cities? (interview by Dr. Th. Meissner)]. MMW Fortschr Med 2003 1.38
17 Buruli ulcer: a systemic disease. Clin Infect Dis 2003 1.16
18 Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages. Am J Trop Med Hyg 2009 1.16
19 Hepatic infestation of Echinococcus multilocularis with extension to regional lymph nodes. Langenbecks Arch Surg 2009 1.12
20 Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study. Malar J 2012 1.10
21 Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J 2002 1.04
22 Immunochromatographic test with recombinant Em18 antigen for the follow-up study of alveolar echinococcosis. Clin Vaccine Immunol 2011 1.03
23 Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004 1.02
24 Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 2008 1.01
25 Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab 2009 1.00
26 Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis 2010 0.99
27 Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography. Abdom Imaging 2007 0.99
28 Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clin Vaccine Immunol 2010 0.98
29 Effect of amphotericin B on larval growth of Echinococcus multilocularis. Antimicrob Agents Chemother 2003 0.98
30 Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malar J 2003 0.92
31 Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis 2012 0.92
32 Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp. Int J Med Microbiol 2003 0.91
33 Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003 0.91
34 Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol 2004 0.91
35 Evidence for a recent horizontal transmission and spatial spread of Wolbachia from endemic Rhagoletis cerasi (Diptera: Tephritidae) to invasive Rhagoletis cingulata in Europe. Mol Ecol 2013 0.90
36 Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients. Clin Dev Immunol 2012 0.89
37 Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Exp Parasitol 2008 0.88
38 Diagnostics in cystic echinococcosis: serology versus ultrasonography. Turk J Gastroenterol 2014 0.88
39 In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother 2006 0.87
40 Human cystic echinococcosis in South Africa. Acta Trop 2011 0.85
41 MoMa from patients with systemic lupus erythematosus show altered adhesive activity. Autoimmunity 2009 0.85
42 First insights into species and genotypes of Echinococcus in South Africa. Vet Parasitol 2013 0.85
43 Survey of public knowledge about Echinococcus multilocularis in four European countries: need for proactive information. BMC Public Health 2008 0.84
44 Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A 2008 0.84
45 A hundred years of controversy about the taxonomic status of Echinococcus species. Acta Trop 2010 0.84
46 Evaluation of a commercial Echinococcus Western Blot assay for serological follow-up of patients with alveolar echinococcosis. Clin Vaccine Immunol 2008 0.83
47 Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg 2010 0.83
48 Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75. J Neurol 2015 0.83
49 Cystic echinococcosis in South Africa: the worst yet to come? Acta Trop 2013 0.82
50 Prognostic factors for invasive aspergillosis in patients with haematological malignancies. Scand J Infect Dis 2009 0.82
51 Palliative operation for the treatment of alveolar echinococcosis. Langenbecks Arch Surg 2008 0.81
52 Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia. Artif Organs 2003 0.81
53 Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun 2002 0.81
54 Prevalence of the metabolic syndrome in southwest Germany. Scand J Clin Lab Invest Suppl 2005 0.80
55 Update on glycopeptide use in german university hospitals. Infection 2004 0.80
56 Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir. AIDS 2004 0.80
57 Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 2004 0.80
58 Special issue: Experimental studies in echinococcosis. Exp Parasitol 2008 0.80
59 Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite. Parasitol Res 2010 0.79
60 Prevalence and diversity of cystic echinococcosis in livestock in Maasailand, Kenya. Parasitol Res 2012 0.78
61 Pregnancy is not a risk factor for gallstone disease: results of a randomly selected population sample. World J Gastroenterol 2005 0.78
62 Detection of low level cryoglobulins by flow cytometry. Cytometry A 2012 0.78
63 Combined albendazole and amphotericin B against Echinococcus multilocularis in vitro. Acta Trop 2010 0.77
64 Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Med Microbiol Immunol 2014 0.77
65 Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterol 2009 0.77
66 In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis. Parasitol Res 2013 0.77
67 Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines. BioDrugs 2003 0.77
68 Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy. Parasit Vectors 2013 0.76
69 Increased expression of CD154 and FAS in SLE patients' lymphocytes. Rheumatol Int 2009 0.76
70 Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume. Ann Surg Oncol 2013 0.76
71 Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model. Blood Purif 2010 0.75
72 Diagnosis of neuroschistosomiasis by antibody specificity index and semi-quantitative real-time PCR from cerebrospinal fluid and serum. J Med Microbiol 2013 0.75
73 [Where Echinococcus lurks and where not. May wild berries still be consumed without concern? (interview by Dr. Judith Neumaier)]. MMW Fortschr Med 2007 0.75
74 [Fox tapeworm is spreading. Avoiding wild berries, caution with pets! (interview by Dr. Beate Schumacher)]. MMW Fortschr Med 2011 0.75